These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32756013)

  • 21. Progeria, rapamycin and normal aging: recent breakthrough.
    Blagosklonny MV
    Aging (Albany NY); 2011 Jul; 3(7):685-91. PubMed ID: 21743107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin decelerates cellular senescence.
    Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin as an antiaging therapeutic?: targeting mammalian target of rapamycin to treat Hutchinson-Gilford progeria and neurodegenerative diseases.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2011 Aug; 14(4):437-41. PubMed ID: 21851176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
    Demidenko ZN; Blagosklonny MV
    Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In search of nutritional anti-aging targets: TOR inhibitors, SASP modulators, and BCL-2 family suppressors.
    Sharma R; Padwad Y
    Nutrition; 2019 Sep; 65():33-38. PubMed ID: 31029919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer.
    Anisimov VN
    Aging (Albany NY); 2013 May; 5(5):337-8. PubMed ID: 23715473
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of mTOR by Rapamycin Aggravates Corneal Epithelial Stem Cell Deficiency by Upregulating Inflammatory Response.
    Park JW; Ko JH; Kim BH; Ryu JS; Kim HJ; Kim MK; Oh JY
    Stem Cells; 2019 Sep; 37(9):1212-1222. PubMed ID: 31102490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect.
    Sousa-Victor P; García-Prat L; Muñoz-Cánoves P
    Oncotarget; 2015 Sep; 6(27):23052-4. PubMed ID: 26375366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells.
    Bu X; Le C; Jia F; Guo X; Zhang L; Zhang B; Wu M; Wei L
    Cancer Biol Ther; 2008 Mar; 7(3):392-6. PubMed ID: 18075305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin retards epigenetic ageing of keratinocytes independently of its effects on replicative senescence, proliferation and differentiation.
    Horvath S; Lu AT; Cohen H; Raj K
    Aging (Albany NY); 2019 May; 11(10):3238-3249. PubMed ID: 31136303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TOR-inhibitors as gero-suppressors.
    Nikiforov M
    Aging (Albany NY); 2015 Dec; 7(12):1030-1. PubMed ID: 26796970
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluorofenidone inhibits UV-A induced senescence in human dermal fibroblasts via the mammalian target of rapamycin-dependent SIRT1 pathway.
    Lei D; Huang Y; Xie H; Yi Y; Long J; Lin S; Huang C; Jian D; Li J
    J Dermatol; 2018 Jul; 45(7):791-798. PubMed ID: 29726032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin, anti-aging, and avoiding the fate of Tithonus.
    Richardson A
    J Clin Invest; 2013 Aug; 123(8):3204-6. PubMed ID: 24063054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relief with rapamycin: mTOR inhibition protects against radiation-induced mucositis.
    Finkel T
    Cell Stem Cell; 2012 Sep; 11(3):287-8. PubMed ID: 22958927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTOR pathway activation drives lung cell senescence and emphysema.
    Houssaini A; Breau M; Kebe K; Abid S; Marcos E; Lipskaia L; Rideau D; Parpaleix A; Huang J; Amsellem V; Vienney N; Validire P; Maitre B; Attwe A; Lukas C; Vindrieux D; Boczkowski J; Derumeaux G; Pende M; Bernard D; Meiners S; Adnot S
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
    Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
    Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.
    Stockklausner C; Raffel S; Klermund J; Bandapalli OR; Beier F; Brümmendorf TH; Bürger F; Sauer SW; Hoffmann GF; Lorenz H; Tagliaferri L; Nowak D; Hofmann WK; Buergermeister R; Kerber C; Rausch T; Korbel JO; Luke B; Trumpp A; Kulozik AE
    Aging (Albany NY); 2015 Nov; 7(11):911-27. PubMed ID: 26546739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.